[go: up one dir, main page]

AU2017900493A0 - Formulations of Cannabinoids for the Treatment of Acne - Google Patents

Formulations of Cannabinoids for the Treatment of Acne

Info

Publication number
AU2017900493A0
AU2017900493A0 AU2017900493A AU2017900493A AU2017900493A0 AU 2017900493 A0 AU2017900493 A0 AU 2017900493A0 AU 2017900493 A AU2017900493 A AU 2017900493A AU 2017900493 A AU2017900493 A AU 2017900493A AU 2017900493 A0 AU2017900493 A0 AU 2017900493A0
Authority
AU
Australia
Prior art keywords
cannabinoids
acne
formulations
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900493A
Inventor
Matthew CALLAHAN
Eugene Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Inc
Filing date
Publication date
Application filed by Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Inc
Publication of AU2017900493A0 publication Critical patent/AU2017900493A0/en
Priority to CA3053503A priority Critical patent/CA3053503C/en
Priority to EP18754824.3A priority patent/EP3582770A4/en
Priority to JP2019544845A priority patent/JP2020508992A/en
Priority to BR112019017049A priority patent/BR112019017049A2/en
Priority to CN201880023591.0A priority patent/CN110769819A/en
Priority to IL268728A priority patent/IL268728B2/en
Priority to NZ756307A priority patent/NZ756307A/en
Priority to US16/486,214 priority patent/US20220323401A1/en
Priority to AU2018221881A priority patent/AU2018221881B2/en
Priority to PCT/AU2018/050045 priority patent/WO2018148786A1/en
Priority to JP2022166140A priority patent/JP2022185150A/en
Abandoned legal-status Critical Current

Links

AU2017900493A 2017-02-15 2017-02-15 Formulations of Cannabinoids for the Treatment of Acne Abandoned AU2017900493A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PCT/AU2018/050045 WO2018148786A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
CN201880023591.0A CN110769819A (en) 2017-02-15 2018-01-24 Cannabinoid formulations for the treatment of acne
EP18754824.3A EP3582770A4 (en) 2017-02-15 2018-01-24 CANNABINOID FORMULATIONS FOR THE TREATMENT OF ACNE
JP2019544845A JP2020508992A (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
BR112019017049A BR112019017049A2 (en) 2017-02-15 2018-01-24 cannabinoid formulations for the treatment of acne
CA3053503A CA3053503C (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
IL268728A IL268728B2 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
NZ756307A NZ756307A (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
US16/486,214 US20220323401A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
AU2018221881A AU2018221881B2 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of acne
JP2022166140A JP2022185150A (en) 2017-02-15 2022-10-17 Formulations of cannabinoids for treatment of acne

Publications (1)

Publication Number Publication Date
AU2017900493A0 true AU2017900493A0 (en) 2017-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448874A4 (en) Compositions for the treatment of disease
EP3448875A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3538078A4 (en) Formulations for efficient delivery of cannabinoids
EP3732195A4 (en) Cytotoxicity-inducing therapeutic agent
EP3481402A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3347368A4 (en) Compounds and formulations for treating ophthalmic diseases
EP3487464A4 (en) Rollator
EP3484504A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3307240A4 (en) Combination therapy for the treatment of cancer
EP3619238A4 (en) Cytotoxicity-inducing therapeutic agent
EP3359192A4 (en) Combination therapy for the treatment of cancer
EP3389645A4 (en) Combinations for the treatment of cancer
EP3548028A4 (en) Treatment of cancer
EP3538219A4 (en) Topical compositions for the treatment of acne
EP3556368A4 (en) Onychomycosis therapeutic agent
EP3490561A4 (en) Combinations for the treatment of cancer
EP3775263A4 (en) Compositions and methods for the treatment of acne
EP3310366A4 (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
EP3352749A4 (en) Compounds and compositions for the treatment of ocular disorders
EP3174525A4 (en) Otic formulations for the treatment of ceruminosis
EP3503887A4 (en) Combinations for the treatment of cancer
EP3472623A4 (en) Exosome-guided treatment of cancer
EP3413827A4 (en) Devices for image-guided light treatment of skin
IL268728A (en) Formulations of cannabinoids for the treatment of acne